Thornton A

ORCID: 0000-0003-2455-7199 · 1 paper in corpus · active 2016
2016
Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer.
Gynecologic oncology reports ·doi:10.1016/j.gore.2016.11.001

•Case describes a response to sunitinib in clear cell ovarian cancer.•Discussion of unique molecular characteristics of clear cell ovarian cancers•Practical points regarding dosing and toxicity when using sunitinib discussed.